Search Results 41-50 of 17292 for egfr

1. Fluorescence in situ hybridization - Cytogenetics Core - Mayo Clinic Research

   Determine the presence or absence of interspecies cells in xenograft or chimeric animal models. Fluorescence in situ hybridization of a locus-specific EGFR ...

2. A Study of Fresolimumab in Patients with Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS) - Mayo Clinic

   To evaluate fresolimumab dose-dependent reduction in proteinuria; To compare the change in renal function (estimated glomerular filtration rate [eGFR]) in ...

3. Evaluation Of Efficacy Of Povetacicept In Adults With Immunoglobulin A Nephropathy (IgAN) - Mayo Clinic

   * Estimated glomerular filtration rate (eGFR) ≥ 30 mL/min/1.73m\^2 * Stable angiotensin converting enzyme inhibitor (ACEi) or angiotensin II receptor ...

4. Nivolumab (intravenous route) - Side effects & uses - Mayo Clinic

   This medicine is also used with chemo medicines containing platinum before having surgery for NSCLC in patients who do not have an abnormal EGFR or ALK gene ...

5. Pembrolizumab and berahyaluronidase alfa-pmph (subcutaneous route) - Side effects & uses - Mayo Clinic

   ... EGFR or ALK gene in patients who have not received other cancer treatments. It is also used alone to treat NSCLC that has spread, whose tumors express PD-L1 ...

6. Clinical trials - Oncology (Medical)

   Additional patients limited to those with EGFR mutations may be enrolled following the initial study period as needed to ensure adequate sample sizes needed to ...

7. Evaluation of N Latex Beta Trace Protein on BN™ Systems as eGFR and RKF Marker - Mayo Clinic

   About this study. The purpose of this study is to test specific analytical performance characteristics of the beta trace protein (BTP) assay on the BN ...

8. Clinical trials - Oncology (Medical)

   Patients with known EGFR (Epidermal growth factor receptor) tyrosine kinase (TK) activating mutations and anaplastic lymphoma kinase (ALK) rearrangements ...

9. Pembrolizumab (intravenous route) - Side effects & uses - Mayo Clinic

   Pembrolizumab injection is used alone to treat non-small cell lung cancer (NSCLC) that has spread, whose tumors express PD-L1 and do not have an abnormal EGFR ...

10. Afatinib (oral route) - Side effects & dosage - Mayo Clinic

    ... (EGFR) genes in patients who have not received any treatments for cancer that has already spread to other parts of the body. This medicine is also used to ...